ArticleCell discovery2020

Characterization of a novel type III CRISPR-Cas effector provides new insights into the allosteric activation and suppression of the Cas10 DNase.

Jinzhong Lin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.